BioSpace News Archive

QIAGEN N.V. announced that its recently launched, environmentally friendlier QIAwave nucleic-acid extraction kits have received the prestigious ACT Environmental Impact Factor Label from My Green Lab, a non-profit organization dedicated to advancing sustainability in scientific research.

Atreca, Inc. announced that it will present at the following upcoming investor conferences.

Rise in number of cancer patients has led to rise in investments from government to establish specialized hospitals, which is expected to drive market revenue growth

Vanda Pharmaceuticals Inc. announced participation at Digestive Disease Week 2022, to be held in San Diego, CA and online from May 21-24, 2022.

The early phase clinical trial results of BBM-H901, the first intravenously injectable hemophilia B gene therapy product developed and tested in Asia, are published in The Lancet Haematology, a top international journal in hematology.

Gracell Biotechnologies Inc. announced that the management team will participate in and attend one-on-one meetings at three investor conferences in June 2022 as follows:

Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced a new patent related to its Drug Delivery System (DDS) platform under development.

Electromed, Inc. announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic Society International Conference in San Francisco, CA.

Abbott (NYSE: ABT) today announced two late-breaking data presentations highlighting both TriClip™, a first-of-its kind minimally invasive tricuspid heart valve repair device, and Navitor™, the company’s latest-generation transcatheter aortic valve implantation (TAVI) system.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing the Phase 1b study of barzolvolimab (CDX-0159) in patients with antihistamine refractory chronic spontaneous urticaria (CSU), has been accepted as a late-breaking electronic poster presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2022.